Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06208709

Carpal Arch Space Augmentation (CASA) Clinical Trial

Led by University of Arizona · Updated on 2026-02-23

116

Participants Needed

1

Research Sites

118 weeks

Total Duration

On this page

Sponsors

U

University of Arizona

Lead Sponsor

N

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a small time period of force is applied, followed by a brief period of no force. The device is intended to be worn during hours of sleep. The efficacy of the treatment is evaluated based on patient reported outcomes. Treatment efficacy will also be evaluated based on comparisons to patient reported outcomes for a SOC treatment.

CONDITIONS

Official Title

Carpal Arch Space Augmentation (CASA) Clinical Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Diagnosed with carpal tunnel syndrome in the right hand or both hands (treatment only on right hand)
Not Eligible

You will not qualify if you...

  • History of musculoskeletal or neurological conditions that may affect symptoms, including arthritis in wrist/hand/finger joints
  • Prior neck trauma, whiplash, or suspected cervical radiculopathy
  • Current or past treatment for cervical radiculopathy or related musculoskeletal issues in neck, shoulder, or upper extremity
  • History of traumatic or chronic neuromusculoskeletal disorders in the tested upper extremity
  • Diagnosed diseases including uncontrolled diabetes, thyroid disease, rheumatoid arthritis, gout, lupus, renal failure, hemodialysis, sarcoidosis, amyloidosis, or other systemic diseases affecting the median nerve
  • Diagnosis of cervical disorders affecting the same side as the test hand such as radiculopathy, spondylosis, tumor, or multiple sclerosis
  • Symptomatic joint diseases in the test hand (e.g., osteoarthritis)
  • Osteoporosis in the test hand
  • History of carpal tunnel release surgery in the test hand
  • Corticosteroid injection for carpal tunnel syndrome in the test hand within 3 months before study start
  • Women who are currently pregnant
  • Scheduled carpal tunnel release surgery for the test hand within 12 weeks
  • Use of pain medication within 2 weeks before study start
  • Participation in other carpal tunnel syndrome treatments or therapies during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Arizona

Tucson, Arizona, United States, 85724

Actively Recruiting

Loading map...

Research Team

Z

Zong-Ming Li, PhD

CONTACT

F

Fernanda Camargo

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here